Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-Based Wound Care Hydrogel

Sonoma Pharmaceuticals, Inc. announced it has received a new 510(k) clearance from the US FDA for its Microcyn technology-based hydrogel, including improved biocompatibility and extended shelf life.